Výsledky vyhledávání - "Thomas E. Cuddy"

Influence of Proteinuria on Cardiovascular Risk and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction

Autor: Thomas E. Cuddy, Charles R.V. Tomson, Jean L. Rouleau, Eugene Braunwald, Hicham Skali, Victoria Bernstein, J. Malcolm O. Arnold, Scott D. Solomon, Marc A. Pfeffer, Bruce Sussex, Powell Jose

Publikováno v: Journal of the American College of Cardiology. 47:1725-1727

To the Editor: Proteinuria is a known predictor of cardiovascular (CV) morbidity and mortality in diabetics, hypertensive patients, and the general population ([1–3][1]), but the impact of proteinuria as a risk factor after acute myocardial infarct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a830413200ca746a76e34334496d2fb1
https://doi.org/10.1016/j.jacc.2006.01.047

Zobrazit plný text záznamu

A Comparison of Management Patterns after Acute Myocardial Infarction in Canada and the United States

Publikováno v: New England Journal of Medicine. 328:779-784

Background There are major differences in the organization of the health care systems in Canada and the United States. We hypothesized that these differences may be accompanied by differences in patient care. Methods To test our hypothesis, we compar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54434cef323ea51f842975c1bacf975b
https://doi.org/10.1056/nejm199303183281108

Zobrazit plný text záznamu

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Autor: Milton Packer, Lemuel A. Moyé, Lofty L. Basta, Jacques R. Rouleau, Gervasio A. Lamas, Greg C. Flaker, John H. Wertheimer, Edward J. Brown, Edward M. Geltman, Jean L. Rouleau, John D. Rutherford, Thomas E. Cuddy, Eugene Braunwald, Barry R. Davis, Steven Goldman, C. Morton Hawkins, Marc A. Pfeffer, Marc Klein

Publikováno v: New England Journal of Medicine. 327:669-677

Background. Left ventricular dilatation and dysfunction after myocardial infarction are major predictors of death. In experimental and clinical studies, long-term therapy with the angiotensin-converting—enzyme inhibitor captopril attenuated ventric

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::21619d134551a54b43338ee4ae24eae9
https://doi.org/10.1056/nejm199209033271001

Zobrazit plný text záznamu

Predictors of Heart Failure in Patients with Stable Coronary Artery Disease: A PEACE Study

Autor: Jean L. Rouleau, Eldrin F. Lewis, Kathleen A. Jablonski, Miguel Zabalgoitia, Marc A. Pfeffer, Thomas E. Cuddy, Judith Hsia, Scott D. Solomon, Eugene Braunwald, Madeline Murguia Rice, Bernard J. Gersh, Thao Huynh, Aldo P. Maggioni, Francesco Clemenza

Background— Heart failure (HF) is a disease commonly associated with coronary artery disease. Most risk models for HF development have focused on patients with acute myocardial infarction. The Prevention of Events with Angiotensin-Converting Enzyme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3c24b55af0ca54a23573fa0b9d27827
https://europepmc.org/articles/PMC3009573/

Zobrazit plný text záznamu

Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function

Autor: Torbjørn Omland, Aldo P. Maggioni, Judith Hsia, Madeline Murguia Rice, Greg C. Flaker, Scott D. Solomon, Nancy L. Geller, Jean L. Rouleau, Michael J. Domanski, Marc S. Sabatine, Kathleen A. Jablonski, Miguel Zabalgoitia, Thomas E. Cuddy

Publikováno v: The American journal of cardiology. 101(4)

Although sudden cardiac death (SCD) has been extensively studied in patients with coronary artery disease (CAD) and low ejection fraction, prediction of SCD among individuals with preserved left ventricular systolic function is less well understood.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::711e227f3e5dbcb9b4f993457559a20a
https://pubmed.ncbi.nlm.nih.gov/18312757

Zobrazit plný text záznamu

Activation of neurohumoral systems following acute myocardial infarction

Autor: John McCans, Victoria Bernstein, M.M.Patricia McEwan, Daniel G. Bichet, Marc Klein, Bruce Sussex, Claude Nadeau, John O. Parker, Marc A. Pfeffer, Francois Sestier, Lemuel A. Moyé, J. Malcolm O. Arnold, Jacques de Champlain, Milton Packer, Gervasio A. Lamas, Thomas E. Cuddy, François Delage, Jean L. Rouleau, Stephen S. Gottlieb

Publikováno v: The American journal of cardiology. 68(14)

Previous studies have indicated that patients with an acute myocardial infarction have marked activation of all neurohumoral systems on admission to the hospital. This activation begins to subside within the first 72 hours so that by 7-10 days, all p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89595dde2a07498c97d4c191b91d09dd
https://pubmed.ncbi.nlm.nih.gov/1684082

Zobrazit plný text záznamu

Selection Bias in the Use of Thrombolytic Therapy in Acute Myocardial Infarction

Autor: Lemuel A. Moyé, Thomas E. Cuddy, Gregory C. Flaker, Richard M. Steingart, Eugene Braunwald, Lofty L. Basta, Gervasio A. Lamas, Edward J. Brown, Marc A. Pfeffer, Bernard J. Gersh, John D. Rutherford, Gilles R. Dagenais, John H. Wertheimer, Edward M. Geltman, Jean L. Rouleau, Milton Packer, Steven Goldman

Publikováno v: JAMA: The Journal of the American Medical Association. 266:528

Objective. —To determine whether clinical selection for thrombolytic therapy for acute myocardial infarction results in a skewed population for subsequent adverse cardiovascular events. Design. —A comparison of the clinical features of the patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4f64234d31372f081243c1c7236c7d52
https://doi.org/10.1001/jama.1991.03470040092028

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání